Name: Drug Resistance in the Treatment of Cancer (Cancer: Clinical Science in Practice) (en Inglés)
Price: 86240.00 CLP
Availability: InStock
Author: Herbert M. Pinedo; Giuseppe Giaccone; Pinedo Herbert M.
ISBN: 9780521030748

portada Drug Resistance in the Treatment of Cancer (Cancer: Clinical Science in Practice) (en Inglés)

Formato

Libro Físico

Editorial

Cambridge University Press

Autor

Herbert M. Pinedo; Giuseppe Giaccone; Pinedo Herbert M.

Año

2007

Idioma

Inglés

N° páginas

340

Encuadernación

Tapa Blanda

ISBN

0521030749

ISBN13

9780521030748

Categorías

Hematología

Drug Resistance in the Treatment of Cancer (Cancer: Clinical Science in Practice) (en Inglés)

Herbert M. Pinedo; Giuseppe Giaccone; Pinedo Herbert M. (Autor) · Cambridge University Press · Tapa Blanda

Libro Físico

$ 86.240

$ 172.480

Ahorras: $ 86.240

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 07 de Mayo y el Viernes 10 de Mayo.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Drug Resistance in the Treatment of Cancer (Cancer: Clinical Science in Practice) (en Inglés)"

The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumours that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the course of their treatment. This book reviews the mechanisms and clinical implications of drug resistance in cancer with unrivalled authority. Chapters cover topics of current clinical concern, including multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support. The authors are among the leading clinicians and investigators in the field. These authoritative volumes in this series are intended for a wide audience of clinicians and researchers with an interest in the applications of biomedical science to the understanding and management of cancer.